Ankylosing Spondylitis: Another Step Toward Individualized Therapy Study IDs factors predicting response to TNF inhibitors Mar 15, 2022
Hopes Dashed for Novel Osteoarthritis Treatment Noninvasive therapy looked like a sure winner until trial results came in Mar 08, 2022
Fibromyalgia Patients See Rapid Benefit From Low-Cal Diet With marked symptom reduction in just 3 weeks, weight loss not a factor Mar 02, 2022
Kids With IBD Need Close Monitoring as They Grow Up Meta-analysis confirms: substantially increased cancer risk in adulthood Mar 02, 2022
10 51˶ With the Lowest Hourly Rate Calculated by annual salary divided by number of hours worked Feb 23, 2022
Dyspnea in Woman With RA Reveals a Diaphragmatic Lipoma MRI can help differentiate these benign soft-tissue masses from more aggressive liposarcomas Feb 22, 2022
Predicting Treatment Response in Inflammatory Muscle Disorders Swedish registry study elicits factors associated with improvement Feb 16, 2022
Acute Muscle Weakness and Skin Rash Following a Lupus Diagnosis Clinicians consider many differentials Feb 14, 2022
Two Years On, Tremfya Still Shines in Psoriatic Arthritis Efficacy increases in long-term extension data Feb 10, 2022
Mystery: Why Would Hand OA Be Less Severe in Black People? Data contrast with previous findings for hip and knee osteoarthritis Feb 04, 2022
Trial Data Confirm Heightened Risks With JAK Inhibitor May help patients and clinicians better weigh benefit against adverse effects Jan 26, 2022
Psoriasis Patients, Docs Want to Do More to Prevent Heart Problems Despite well-known cardiovascular risks, most patients currently undertreated Jan 19, 2022
Don't Expect Much From COVID Vax in This Patient Group With rituximab on board, even third doses didn't induce meaningful antibody response Jan 13, 2022
Muddled Picture for Antidepressant as Osteoarthritis Pain Reliever Trial in primary care setting fails to confirm benefit seen in specialty clinics Jan 06, 2022
Success for Upadacitinib in PsA, Despite Concerns JAK inhibitor nabs new indication after FDA called for boxed warnings on the class Dec 28, 2021
Hydroxychloroquine Linked to Less Heart Risk in RA, Lupus Current use of the antimalarial especially was particularly associated with less thrombosis Dec 28, 2021
Another Trial, Another PRP Flop in Osteoarthritis Fails to outperform saline in randomized trial Nov 23, 2021
Another Study Confirms Gout Benefit With SGLT2 Inhibitors Gout risk reduction was significantly better than with DPP-4 inhibitors Nov 19, 2021
Biologic Disappoints for Arthritis Achilles' Inflammation But phase III trial did find some patient-oriented benefits Nov 11, 2021
For Systemic JIA, Start Biologics Early Observational study shows excellent efficacy in systemic pediatric arthritis Nov 10, 2021
HAE Still Drawing Attention From Drugmakers Two new products show midstage promise in hereditary angioedema Nov 10, 2021
Secukinumab: An Up-and-Coming Option in Giant Cell Arteritis? Phase II trial found sustained remission with steroid-sparing effects Nov 10, 2021
Voclosporin Benefits in Nephritis Persist at 30 Months No new safety signals seen in long-term extension for lupus nephritis Nov 09, 2021
Avacopan Helps Vasculitis Patients With Renal Impairment Wean Off Steroids Patients saw better eGFR recovery compared with prednisone Nov 08, 2021
Vitamin D and Disease Prevention: Worth Another Look? Incidence of autoimmune disease decreased by 25-30% with dietary supplements Nov 08, 2021
Guselkumab Response Durable in Psoriatic Arthritis Skin and joint improvements persisted through 2 years of follow-up Nov 08, 2021
Early Biologics Better in Juvenile Idiopathic Arthritis After 2 years, more patients on combo biologic/DMARD regimen had inactive disease Nov 08, 2021
Brepocitinib Shows Promise in Phase II Trial for PsA Oral tyrosine kinase 2/JAK-1 inhibitor improved both joint and skin manifestations Nov 07, 2021
Could This Biologic Drug Work in Patients Lacking Its Target? Bizarre finding with omalizumab Nov 07, 2021
Targeting IL-23 Succeeds in Psoriatic Arthritis Patients had active, longstanding disease and inadequate responses to other agents Nov 07, 2021
Can Abatacept Reverse Early Rheumatoid Arthritis? At-risk patients showed improvements in inflammation -- and also delays in disease onset Nov 06, 2021
Mixed Results With Anti-Interleukin Biologics in Asthma One shows promise; another fails miserably (and mysteriously) Oct 27, 2021
No Love for PRP in Ankle Osteoarthritis Trial Dutch researchers throw cold water on popular therapy Oct 26, 2021
Following Rituximab With Second Biologic Helpful in Lupus Trial may provide answer for patients who don't respond to B-cell depletion Oct 25, 2021
How Should Patients With Autoimmune Diseases Approach COVID Vaccination? Mixed messaging and a lack of tailored research leaves providers and patients in the dark Oct 22, 2021
First Interchangeable Humira Biosimilar Approved Cyltezo nabs coveted "interchangeable" status for RA, inflammatory bowel disease, and more Oct 18, 2021
FDA Gives Thumbs Up to ANCA-Associated Vasculitis Drug Approval granted to avacopan despite advisory committee concerns Oct 08, 2021
Is This the Future of Corticosteroids? Novel agent, aimed at doing away with adverse metabolic effects, proves mettle in DMD Oct 05, 2021
Olfactory Loss Common in Sjogren's Syndrome Objective impairments in olfaction correlated with disease activity and symptoms Sep 29, 2021